Comparing Characteristics of Pelvic High-grade Serous Carcinomas with and without Breast Cancer Gene Variants on MR Imaging

被引:0
|
作者
Saida, Tsukasa [1 ]
Shikama, Ayumi [2 ]
Mori, Kensaku [1 ]
Ishiguro, Toshitaka [1 ]
Minaguchi, Takeo [2 ]
Satoh, Toyomi [2 ]
Nakajima, Takahito [1 ]
机构
[1] Univ Tsukuba, Dept Radiol, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Dept Obstet & Gynecol, Fac Med, Tsukuba, Ibaraki, Japan
关键词
breast cancer; cancer; high-grade serous carcinoma; magnetic resonance imaging; ovary; SOMATIC MUTATIONS; INVASION PATTERNS; FALLOPIAN-TUBE; OVARIAN; BENEFIT; BRCA1; GERMLINE; SURVIVAL; PLATINUM;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To compare MRI findings of high-grade serous carcinoma (HGSC) with and without breast cancer (BRCA) gene variants to explore the feasibility of MRI as a genetic predictor. Methods: We retrospectively reviewed MRI data from 16 patients with BRCA variant-positive (11 patients of BRCA1 and 5 patients of BRCA2 variant-positive) and 32 patients with BRCA variant-negative HGSCs and evaluated tumor size, appearance, nature of solid components, apparent diffusion coefficient (ADC) value, time-intensity curve, several dynamic contrast-enhanced curve descriptors, and nature of peritoneal metastasis. Age, primary site, tumor stage, bilaterality, presence of lymph node metastasis, presence of peritoneal metastasis, and tumor markers were also compared between the groups with the Mann-Whitney U and chi-square tests. Results: The mean tumor size of BRCA variant-positive HGSCs was 9.6 cm, and that of variant-negative HGSCs was 6.8 cm, with no significant difference (P = 0.241). No significant difference was found between BRCA variant-positive and negative HGSCs in other evaluated factors, except for age (mean age, 53 years old; range, 32-78 years old for BRCA variant-positive and mean age, 61 years old; range, 44-80 years old for BRCA variant-negative, P = 0.033). Comparing BRCA1 variant-positive and BRCA2 variant-positive HGSCs, BRCA1 variant-positive HGSCs were larger (P = 0.040), had greater Max enhancement (P = 0.013), Area under the curve (P = 0.013), and CA125 (P = 0.038), and had a higher frequency of lymph node metastasis (P = 0.049), with significance. Conclusion: There was no significant difference in the MRI findings between patients with HGSCs with and without BRCA variants. Although studied in small numbers, BRCA1 variant-positive HGSCs were larger and more enhanced than BRCA2 variant-positive HGSCs with higher CA125 and more frequent lymph node metastases, and may represent more aggressive features.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [21] Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma
    Wallbillich, John J.
    Morris, Robert T.
    Ali-Fehmi, Rouba
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : 381 - 386
  • [22] Enrichment of high-grade tumors in breast cancer gene expression studies
    van Seijen, M.
    Mooyaart, A. L.
    Mulder, L.
    Hoogstraat, M.
    Drukker, C. A.
    Loo, C. E.
    Pouw, B.
    Sonke, G. S.
    Wesseling, J.
    Lips, E. H.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 327 - 335
  • [23] Enrichment of high-grade tumors in breast cancer gene expression studies
    M. van Seijen
    A. L. Mooyaart
    L. Mulder
    M. Hoogstraat
    C. A. Drukker
    C. E. Loo
    B. Pouw
    G. S. Sonke
    J. Wesseling
    E. H. Lips
    Breast Cancer Research and Treatment, 2018, 168 : 327 - 335
  • [24] Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas
    Dowson, Cassandra B.
    Stewart, Colin
    O'Sullivan, Sarah
    Pachter, Nicholas
    Schofield, Lyn
    Cohen, Paul A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (01) : 94 - 99
  • [25] Benchmarking of Approaches for Gene Copy-Number Variation Analysis and Its Utility for Genetic Aberration Detection in High-Grade Serous Ovarian Carcinomas
    Grebnev, Pavel Alekseevich
    Meshkov, Ivan Olegovich
    Ershov, Pavel Viktorovich
    Makhotenko, Antonida Viktorovna
    Azarian, Valentina Bogdanovna
    Erokhina, Marina Vyacheslavovna
    Galeta, Anastasiya Aleksandrovna
    Zakubanskiy, Aleksandr Vladimirovich
    Shingalieva, Olga Sergeevna
    Tregubova, Anna Vasilevna
    Asaturova, Aleksandra Vyacheslavovna
    Yudin, Vladimir Sergeevich
    Yudin, Sergey Mihaylovich
    Makarov, Valentin Vladimirovich
    Keskinov, Anton Arturovich
    Makarova, Anna Sergeevna
    Snigir, Ekaterina Andreevna
    Skvortsova, Veronika Igorevna
    CANCERS, 2024, 16 (19)
  • [26] High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes
    Nougaret, Stephanie
    Lakhman, Yulia
    Gonen, Mithat
    Goldman, Debra A.
    Micco, Maura
    D'Anastasi, Melvin
    Johnson, Sarah A.
    Juluru, Krishna
    Arnold, Angela G.
    Sosa, Ramon E.
    Soslow, Robert A.
    Vargas, Hebert Alberto
    Hricak, Hedvig
    Kauff, Noah D.
    Sala, Evis
    RADIOLOGY, 2017, 285 (02) : 472 - 481
  • [27] Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms
    Davidson, Natalie R.
    Barnard, Mollie E.
    Hippen, Ariel A.
    Campbell, Amy
    Johnson, Courtney E.
    Way, Gregory P.
    Dalley, Brian K.
    Berchuck, Andrew
    Salas, Lucas A.
    Peres, Lauren C.
    Marks, Jeffrey R.
    Schildkraut, Joellen M.
    Greene, Casey S.
    Doherty, Jennifer A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (08) : 1114 - 1125
  • [28] Diffusion-Weighted Magnetic Resonance Imaging and Morphological Characteristics Evaluation for Outcome Prediction of Primary Debulking Surgery for Advanced High-Grade Serous Ovarian Carcinoma
    Li, Haiming
    Lu, Jing
    Deng, Lin
    Guo, Qinhao
    Lin, Zijing
    Zhao, Shuhui
    Ge, Huijuan
    Qiang, Jinwei
    Gu, Yajia
    Liu, Zaiyi
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (05) : 1340 - 1349
  • [29] Immunohistochemical Expression of p53 Gene and Clinicopathological Assessment of Low-grade Serous Ovarian Cancer and High-grade Serous Ovarian Cancer: A Cohort Study
    Bazard, Geeta
    Vashist, Minakshi
    Singh, Sunita
    Rohilla, Gulshan
    Paliwal, Nidhi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (12) : QC10 - QC14
  • [30] "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer
    Seidman, Jeffrey D.
    Zhao, Po
    Yemelyanova, Anna
    GYNECOLOGIC ONCOLOGY, 2011, 120 (03) : 470 - 473